Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives

Abstract

Proton magnetic resonance spectroscopy (1H-MRS) was applied to characterize intracranial tumours of different hystological types. Seventy patients with intracranial neoplasms were studied before receiving surgery, radiotherapy or chemotherapy. All tumours were characterized by reduced or absentN-acetylaspartate and increased signal from choline-containing compounds. Distinctive patterns were observed only for primitive brain neoplasms; high-grade gliomas were differentiated from low-grade ones by higher levels of choline-containing compounds. The metabolic aspects of metastatic lesions were similar to high-grade gliomas. These results, together with the limitations of1HMRS and future applications are reviewed.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Alger JR, Frank JA, Bizzi A, Fulham MJ, DeSouza BX, Duhaney MO, Inscoe SW, Black JL, Zijl PCM van, Moonen CTW, Di Chiro G (1990) Metabolism of human gliomas: assessment with H1-MR spectroscopy and F fluorodeoxyglucose PET. Radiology 177:633–641

  2. 2.

    Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333–348

  3. 3.

    Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R, Hamburger C (1989) Noninvasive differentiation of tumors with use of localized H1-MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 127:541–548

  4. 4.

    Bruhn H, Michaelis T, Merborldt KD, Hanicke W, Gyngell ML, Hamburger C, Frahm J (1992) On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro. NMR Biomed 5:253–258

  5. 5.

    Demaerel P, Johannik K, Van Hecke P, Van Ongeval C, Verellen S, Marchal G, Wilms G, Plets C, Goffin J, Van Calenbergh F, Lamens M, Baert AL (1991) Localized Hl-MR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 15:67–76

  6. 6.

    Frahm J, Bruhn H, Hanicke W, Merborldt KD, Mursch K, Markakis E (1991) Localized proton NMR spectroscopy of brain tumors using shortecho time STEAM sequences. J Comput Assist Tomogr 15:915–922

  7. 7.

    Fulham MJ, Bizzi A, DietzMJ, Shih HHL, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G (1992) Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185:675–686

  8. 8.

    Gadian DG, Bates TE, Williams SR, Bell JD, Austin SJ, Connelly (1991) Approaches to editing, assignment and interpretation of proton spectra. ANMR Biomed 4:47–116

  9. 9.

    Gideon P, Henriksen O, Arlien-Soborg P, Sperling B (1992) Reappearance of lactate in chronic infarction measured by H-1 MRS. 11th Annual meeting of the Society of Magnetic Resonance in Medicine, Berlin. Book of Abstracts, SMR, Berkley, California, p 1908

  10. 10.

    Gill SS, Thomas DGT, Van Bruggen N, Gadian DG, Peden CJ, Bell JD, Cox IJ, Menon DK, Iles RA, Bryant DJ, Courts GA (1990) Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 14:497–504

  11. 11.

    Haase A, Frahm J, Haenicke W, Matthei D (1985) II NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30:341–344

  12. 12.

    Heindell W, Herholz K, Kugel H, Luyten PR, Bunke J, Heiss WD, Lackner K (1992) Combined HI-MR spectroscopic imaging and F-18 FDG-PET demonstrate metabolic states that imply malignancy in human gliomas. 11th Annual meeting of the Society of Magnetic Resonance in Medicine. Berlin. Book of Abstracts, SMR, Berkley, California, p 51

  13. 13.

    Howe FA, Maxwell RJ, Saunders DE, Brown MM, Griffith JR, (1993) Proton spectroscopy in vivo. Magn Reson Q 9:31–59

  14. 14.

    Howells SL, Maxwell RJ, Griffith JR (1992) Classification of tumor 1H NMR spectra by pattern recognition. NMR Biomed 5:59–64

  15. 15.

    Kinoshita Y, Kajiwara H, Yokota A, Koga Y (1994) Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35: 606–613

  16. 16.

    Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system, 2nd edn. Springer, Berlin Heidelberg New York

  17. 17.

    Klose U (1990) In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 14:26–30

  18. 18.

    Kuesel AC, Sutherland GR, Halliday W, Smith ICP (1994) H1-MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 7:149–155

  19. 19.

    Kugel H, Heindel W, Ernestus R-T, Bunke J, Mesnil R du, Friedmann G (1992) Spectral patterns detected with localized Hl-MR spectroscopy. Radiology 183:701–709

  20. 20.

    Luyten PR, Marien AJH, Heindel W, Gerwen PHJ van, Herholz K, Hollander JA, de, Friedmann G, Heiss W-D (1990) Metabolic imaging of patients with intracranial tumors: H1-MR spec troscopic imaging and PET Radiology 176:791–799

  21. 21.

    Maxwell RJ, Prysor-Jones RA, Jenkins IS, Griffith JR (1988) Vasoactive intestinal peptide stimulates glycolysis in rat pituitary tumors;1H NMR detection of lactate in vivo. Biochem Biophys Acta 968:86–90

  22. 22.

    McComb RD, Bigner DD (1984) The biology of malignant glioma: a comprehensive survey. Clin Neuropathol 3 93–106

  23. 23.

    Nadler JV, Cooper JR (1982)N-Acetyl-spl-aspartic acid content of human neural tumors and bovine peripheral nervous tissues. J Neurochem 19: 313–319

  24. 24.

    Nagendank W, Sauter R, Brown TR, Jeffrey L, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BCP, Mengeot M, Moser E, Padavic-Shaller K, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA (1996) Proton MR spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg (in press)

  25. 25.

    Ott D, Henning J, Ernst T (1993) Human brain tumors: assessment with in vivo proton spectroscopy. Radiology 186:745–752

  26. 26.

    Segebarth CM, Baleriaux DF, Luyten PR, Hollander JA den, (1990) Detection of metabolic heterogeneity of human intracranial tumors in vivo by H1 NMR spectroscopic imaging. Magn Reson Med 13:62–76

  27. 27.

    Simmons ML, Frondoza CG, Coyle IT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45 37–45

  28. 28.

    Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW (1994) What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 241:354–371

Download references

Author information

Correspondence to Andrea Falini.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Falini, A., Calabrese, G., Origgi, D. et al. Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives. J Neurol 243, 706–714 (1996). https://doi.org/10.1007/BF00873976

Download citation

Key words

  • Brain metabolism Brain tumours

Magnetic resonance spectroscopy

  • Brain metabolism Brain tumours